FDA Inspection 827235 — Blood Bank of Alaska, Inc.

Blood Bank of Alaska, Inc. — FEI 3071403

The FDA completed an inspection of Blood Bank of Alaska, Inc. on March 8, 2013 in Anchorage, AK. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 8, 2013
Fiscal Year
2013
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Anchorage, AK (United States)

Citations

IDCFRDescription
1503021 CFR 606.60(b)Equipment calibration frequency
16021 CFR 606.160(a)(1)Person performing, test results, interpretation
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs